Search Results - "psoriasis"

Sociodemographic and Environmental Determinants of Regional Prevalence of Psoriasis in Germany: A Spatiotemporal Study of Ambulatory Claims Data by Valerie Andrees, Sandra Wolf, Marie Sander, Matthias Augustin, Jobst Augustin

Connect to this object online.

Comparative Evaluation of the Treatment Efficacy and Safety of TNFα and IL12/23 Inhibitors in Children With Psoriasis by Nikolay N. Murashkin, Eduard T. Ambarchian

Connect to this object online.

[Translated article] Quality Assessment of Clinical Practice Guidelines on the Treatment of Psoriasis Using the AGREE II Tool by C. Montesinos-Guevara, A. Andrade Miranda, E. Bedoya-Hurtado, C.M. Escobar Liquitay, J.V.A. Franco, D. Simancas-Racines, Y. Sami Amer, R.W.M. Vernooij, A. Viteri-García

Connect to this object online.

The Use of Metrics in Daily Practice and the Perception of Psoriasis-Associated Comorbidities: Discrepancies Between Research and Real-World by Hillary T, Lambert J

Connect to this object online.

Efficacy of Brodalumab in Patients with Psoriasis and Risk Factors for Treatment Failure: A Review of Post Hoc Analyses by Mark G. Lebwohl, April W. Armstrong, Andrew F. Alexis, Edward L. Lain, Abby A. Jacobson

Connect to this object online.

CD137: A Member of the TNFR Family - in Psoriasis Skin Lesions in Comparison with Normal Skin Specimens by Parvin Rajabi, Syed Mehdi Eftekhari, Azadeh Kadkhodaii, Amirhosein Kefayat

Connect to this object online.

Behcet's-like disease induced by secukinumab in a patient with psoriasis: a case report and literature review by Kecen Liu, Jingru Sun

Connect to this object online.

[Artículo traducido] Brote de psoriasis pustulosa tratado con suplemento de calcio: caso clínico by F.Z. Agharbi, S. Chiheb

Connect to this object online.

Soluble Receptor for Advanced Glycation End Products: A Novel Biomarker for Psoriasis Severity with Therapeutic Implications? by Aleksandra Batycka-Baran, Wojciech Baran, Danuta Nowicka-Suszko, Jacek C. Szepietowski

Connect to this object online.

Development, Feasibility, and Acceptability of the Electronic Patient Benefit Index for Psoriasis in Clinical Practice: Mixed Methods Study by Marina Otten, Vahid Djamei, Matthias Augustin

Connect to this object online.

Differential Diagnosis of Nail Psoriasis and Onychomycoses: A Report Based on 40 Years of Specialised Nail Consultations by Eckart Haneke

Connect to this object online.

Tildrakizumab for the Treatment of Moderate-to-Severe Psoriasis: Results from 52 Weeks Real-Life Retrospective Study by Ruggiero A, Fabbrocicni G, Cacciapuoti S, Potestio L, Gallo L, Megna M

Connect to this object online.

Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review by Tiago Torres, Jordi Galván, Nigel Crutchley, Morten Praestegaard, Lars Iversen, Paolo Gisondi, José Manuel Carrascosa, Bruno Halioua, Anthony Bewley, Andreas Pinter

Connect to this object online.

Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study by Juul M.P.A. van den Reek, Lieke J. van Vugt, Martijn B.A. van Doorn, Gayle E. van der Kraaij, Wim J.A. de Kort, Georges P.H. Lucker, Barbara Horvath, M. David Njoo, H. Jorn Bovenschen, Paul M. Ossenkoppele, Marjolein S. De Bruin-Weller, Marjan de Groot, Roland Mommers, Ruud L.M.A. Prevoo, Peter C.M. van de Kerkhof, Phyllis I. Spuls, Wietske Kievit, Elke M.G.J. de Jong

Connect to this object online.

FR - El papel de la dieta mediterránea en el tratamiento de la psoriasis by E. Berna-Rico, D. Fernandez-Nieto, A. Gonzalez-Cantero

Connect to this object online.

Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study by Laura Gnesotto, Guido Mioso, Federico Bardazzi, Federica Filippi, Vito Di Lernia, Alberico Motolese, Sergio Di Nuzzo, Andrea Conti, Federica Arginelli, Monica Corazza, Giulia Odorici, Alessandro Borghi, Paolo Gisondi, Luigi Naldi, Paolo Dapavo, Aurora Parodi, Martina Burlando, Stefano Piaserico

Connect to this object online.

Annual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece [Corrigendum] by Fragoulakis V, Raptis E, Vitsou E, Maniadakis N

Connect to this object online.

Tildrakizumab for the treatment of moderate-to-severe psoriasis: a 52-week, real-world Portuguese multicentric study by Tiago Torres, Paulo Varela, Pedro Mendes Bastos, Sofia Magina, Martinha Henrique, Paulo Ferreira

Connect to this object online.

Study of the Visceral Adipose Tissue in a Cohort of Patients with Moderate-Severe Psoriasis Treated with Biological Therapy by Ricardo Ruiz-Villaverde, Jose Carlos Ruiz-Carrascosa

Connect to this object online.

Real-world treatment patterns and healthcare costs in patients with psoriasis taking systemic oral or biologic therapies by Sydney Thai, Joe Zhuo, Yichen Zhong, Qian Xia, Xiu Chen, Ying Bao, Devender Dhanda, Lawshia Priya, Jashin J. Wu

Connect to this object online.